"When treating millions of people with medications like semaglutide, even relatively rare side effects will occur in a large number of people," said Susan Yanovski, MD, senior scientific advisor for clinical obesity research and codirector of the National Institute of Diabetes and Digestive and Kidney Diseases' Office of Obesity Research(3 Trusted Source As Semaglutide's Popularity Soars, Rare but Serious Adverse Effects Are Emerging Go to source)
Regardless of whether a pharmacy is accredited or not, the actual compound is not monitored, regulated or tested by the FDA
If a plateau extends beyond 6 weeks and you are not yet at maximum dose, escalating to the next dose level is the standard approach
No, muscle lost during GLP-1 therapy can be rebuilt through resistance training and proper nutrition, though prevention is significantly more efficient than regrowth
Food and Drug Administration (FDA) for safety, effectiveness, or quality
Wilsons disease or copper overload